Cargando…

Minimal change disease relapse following SARS-CoV-2 mRNA vaccine

Detalles Bibliográficos
Autores principales:	Kervella, Delphine, Jacquemont, Lola, Chapelet-Debout, Agnès, Deltombe, Clément, Ville, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098029/ https://www.ncbi.nlm.nih.gov/pubmed/33964312 http://dx.doi.org/10.1016/j.kint.2021.04.033

Ejemplares similares

Atypical HUS relapse triggered by COVID-19
por: Ville, Simon, et al.
Publicado: (2021)

Collapsing glomerulopathy in a patient with APOL1 intermediate-risk genotype triggered by lupus nephritis and SARS-CoV-2 infection: lessons for the clinical nephrologist
por: Masset, Christophe, et al.
Publicado: (2021)

Eosinophilia Due to Central Venous Catheter in Hemodialysis Patients
por: Chapelet-Debout, Agnès, et al.
Publicado: (2021)

Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine
por: Masset, Christophe, et al.
Publicado: (2021)

Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine”
por: Schwotzer, Nora, et al.
Publicado: (2021)

A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response
por: Masset, Christophe, et al.
Publicado: (2021)

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
por: Holzworth, Amy, et al.
Publicado: (2021)

Relapse of minimal change disease and inactivated SARS-CoV-2 vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Ramsay Hunt syndrome following mRNA SARS-COV-2 vaccine()
por: Rodríguez-Martín, Minerva, et al.
Publicado: (2022)

Passive inhaled mRNA vaccination for SARS-Cov-2
por: Yeo, Wee Song, et al.
Publicado: (2021)

NMOSD typical brain lesions after COVID-19 mRNA vaccination
por: Lévi-Strauss, Julie, et al.
Publicado: (2022)

Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine
por: Salem, Fadi, et al.
Publicado: (2021)

Relapse of minimal change disease after inactivated SARS-CoV-2 vaccination: case report
por: Özkan, Gülsüm, et al.
Publicado: (2021)

Note for “Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination”()
por: Rodríguez-Martín, Minerva
Publicado: (2022)

SARS-CoV-2 mRNA vaccination, prostate cancer and steroids: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Relapsed Disciform Stromal Herpetic Keratitis and mRNA COVID-19 Vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
por: Arismendez, Alan A., et al.
Publicado: (2023)

Parsonage Turner Syndrome Following Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2022)

Small-Fiber Neuropathy After Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2023)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Relapse of class V lupus nephritis after vaccination with COVID-19 mRNA vaccine
por: Tuschen, Katharina, et al.
Publicado: (2021)

Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2
por: Oniszczuk, Julie, et al.
Publicado: (2021)

Seroconversion after SARS-CoV-2 mRNA booster vaccine in cancer patients
por: Patelli, Giorgio, et al.
Publicado: (2022)

Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Delayed skin reactions and mRNA vaccines against SARS-CoV-2: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
por: Zhang, Na-Na, et al.
Publicado: (2022)

Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)

Acute myopericarditis after administration of mRNA vaccines against the SARS-CoV-2 virus()
por: Gómez Martín, Alba María, et al.
Publicado: (2022)

SARS-CoV-2 mRNA Vaccination-induced Autoimmune Polyarthritis-like Rheumatoid Arthritis
por: Abe, Nobuya, et al.
Publicado: (2022)

Comment on: Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination
por: Panigrahi, Pradeep K
Publicado: (2022)

De Novo and Relapsing Glomerulonephritis following SARS-CoV-2 mRNA Vaccination in Microscopic Polyangiitis
por: Davidovic, Tamara, et al.
Publicado: (2021)

Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
por: Xu, Xingli, et al.
Publicado: (2022)

Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients
por: Yanay, Noa Berar, et al.
Publicado: (2021)

Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients
por: Boyarsky, Brian J., et al.
Publicado: (2021)

A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients
por: Masset, Christophe, et al.
Publicado: (2022)

Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination
por: Hsu, Lea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n7df7m4clun3rtgv3f3g7h9v21